Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) versus Placebo (2013–2015)

Grant type:
Eli Lilly Australia Pty Ltd
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Eli Lilly Australia Pty Limited